- Home
- Life Sciences
- Surgical Kits
Surgical Kits Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Anticoccidial Drugs Market Analysis
Anticoccidial Drugs Market Size (2021 to 2030)
The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.
Impact of COVID-19 on the Global Anticoccidial Drugs Market
The COVID-19 pandemic has had a significant impact on the global anticoccidial drugs market. The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency.
Market Drivers
YOY growth in the prevalence of coccidiosis and increasing focus on animal health primarily accelerates the global anticoccidial drugs market. Anticoccidial drugs are the agents used to treat, prevent, and control coccidial infections.
Market Restraints
However, the need for more skilled persons in manufacturing appropriate drugs with correct dosage forms slowly restricts the global anticoccidial drug market. In addition, the availability of other drugs at a lower cost and fluctuations in the prices of final products due to less availability of raw materials are expected to limit the growth of the global anticoccidial drugs market.
Key Market Players
Noteworthy companies in the global anticoccidial drugs market include Bayer Health Care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.
